148 related articles for article (PubMed ID: 12200107)
1. Linked unresponsiveness: early cytokine gene expression profiles in cardiac allografts following pretreatment of recipients with bone marrow cells expressing donor MHC alloantigen.
Spriewald BM; Billing JS; Ensminger SM; Morris PJ; Wood KJ
Cytokine; 2002 Jul; 19(1):6-13. PubMed ID: 12200107
[TBL] [Abstract][Full Text] [Related]
2. Pretransplant administration of a single donor class I major histocompatibility complex molecule is sufficient for the indefinite survival of fully allogeneic cardiac allografts: evidence for linked epitope suppression.
Wong W; Morris PJ; Wood KJ
Transplantation; 1997 May; 63(10):1490-4. PubMed ID: 9175815
[TBL] [Abstract][Full Text] [Related]
3. Predominant expression of T helper 2 cytokines and altered expression of T helper 1 cytokines in long-term allograft survival induced by intrathymic immune modulation with donor class I major histocompatibility complex peptides.
Shirwan H; Barwari L; Khan NS
Transplantation; 1998 Dec; 66(12):1802-9. PubMed ID: 9884279
[TBL] [Abstract][Full Text] [Related]
4. Syngeneic bone marrow expressing a single donor class I MHC molecule permits acceptance of a fully allogeneic cardiac allograft.
Wong W; Morris PJ; Wood KJ
Transplantation; 1996 Nov; 62(10):1462-8. PubMed ID: 8958273
[TBL] [Abstract][Full Text] [Related]
5. Real-time polymerase chain reaction analysis reveals an evolution of cytokine mRNA production in allograft acceptor mice.
Xia D; Sanders A; Shah M; Bickerstaff A; Orosz C
Transplantation; 2001 Sep; 72(5):907-14. PubMed ID: 11571458
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of transforming growth factor-beta and eosinophil infiltration is associated with the development of transplant arteriosclerosis in long-term surviving cardiac allografts.
Spriewald BM; Ensminger SM; Billing JS; Morris PJ; Wood KJ
Transplantation; 2003 Oct; 76(7):1105-11. PubMed ID: 14557761
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-gamma in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy.
Mottram PL; Han WR; Purcell LJ; McKenzie IF; Hancock WW
Transplantation; 1995 Feb; 59(4):559-65. PubMed ID: 7878761
[TBL] [Abstract][Full Text] [Related]
8. Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for maintenance of tolerance to alloantigen in vivo in anti-CD4 treated recipients.
Hamano K; Rawsthorne MA; Bushell AR; Morris PJ; Wood KJ
Transplantation; 1996 Sep; 62(6):856-60. PubMed ID: 8824489
[TBL] [Abstract][Full Text] [Related]
9. Helper T lymphocyte unresponsiveness to cardiac allografts following transient depletion of CD4-positive cells. Implications for cellular and humoral responses.
Bishop DK; Li W; Chan SY; Ensley RD; Shelby J; Eichwald EJ
Transplantation; 1994 Sep; 58(5):576-84. PubMed ID: 7522364
[TBL] [Abstract][Full Text] [Related]
10. CD28 blockade alters cytokine mRNA profiles in cardiac transplantation.
Lin H; Wei RQ; Goodman RE; Bolling SF
Surgery; 1997 Aug; 122(2):129-37. PubMed ID: 9288115
[TBL] [Abstract][Full Text] [Related]
11. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts.
Binder J; Lehmann M; Graser E; Hancock WW; Watschinger B; Onodera K; Sayegh MH; Volk HD; Kupiec-Weglinski JW
Transplantation; 1996 Mar; 61(5):804-11. PubMed ID: 8607187
[TBL] [Abstract][Full Text] [Related]
12. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
[TBL] [Abstract][Full Text] [Related]
13. Anti-TNF antibody modulates cytokine and MHC expression in cardiac allografts.
Wei RQ; Schwartz CF; Lin H; Chen GH; Bolling SF
J Surg Res; 1999 Feb; 81(2):123-8. PubMed ID: 9927530
[TBL] [Abstract][Full Text] [Related]
14. Thymus-dependent, anti-CD4-induced tolerance to rat cardiac allografts.
Jaques BC; Ahmiedat H; Alastair Gracie J; Marshall HE; Middleton SE; Bolton EM; Bradley JA
Transplantation; 1998 Nov; 66(10):1291-9. PubMed ID: 9846511
[TBL] [Abstract][Full Text] [Related]
15. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen.
Arima T; Lehmann M; Flye MW
Transplantation; 1997 Jan; 63(2):284-92. PubMed ID: 9020332
[TBL] [Abstract][Full Text] [Related]
16. CTLA4-Ig plus bone marrow induces long-term allograft survival and donor specific unresponsiveness in the murine model. Evidence for hematopoietic chimerism.
Pearson TC; Alexander DZ; Hendrix R; Elwood ET; Linsley PS; Winn KJ; Larsen CP
Transplantation; 1996 Apr; 61(7):997-1004. PubMed ID: 8623206
[TBL] [Abstract][Full Text] [Related]
17. Nondepleting anti-CD4 monoclonal antibody enhances the ability of oral alloantigen delivery to induce indefinite survival of cardiac allografts: oral tolerance to alloantigen.
Niimi M; Witzke O; Bushell A; Hara M; Morris PJ; Wood KJ
Transplantation; 2000 Nov; 70(10):1524-8. PubMed ID: 11118100
[TBL] [Abstract][Full Text] [Related]
18. Prolonged survival of mouse cardiac allografts after CD4 or CD8 monoclonal antibody therapy is associated with selective intragraft cytokine protein expression: interleukin (IL)-4 and IL-10 but not IL-2 or interferon-gamma.
Hancock W; Mottram PL; Purcell LJ; Han WR; Pietersz GA; McKenzie IF
Transplant Proc; 1993 Oct; 25(5):2937-8. PubMed ID: 8212290
[No Abstract] [Full Text] [Related]
19. The kinetics of tolerance induction by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus intravenous donor alloantigen administration.
Motoyama K; Arima T; Yu S; Lehmann M; Flye MW
Transplantation; 2000 Jan; 69(2):285-93. PubMed ID: 10670640
[TBL] [Abstract][Full Text] [Related]
20. Intragraft cytokine mRNA expression in rejecting and non-rejecting vascularized xenografts.
Lorant T; Krook H; Wilton J; Olausson M; Tufveson G; Korsgren O; Johnsson C
Xenotransplantation; 2003 Jul; 10(4):311-24. PubMed ID: 12795680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
